ArticleMaterials today. Bio2026

A molecular engineered NIR-II fluorescence agent with enhanced radiative and non-radiative decay for precision prostate cancer bone metastasis theranostics.

Yan Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.